EPISODE · Dec 16, 2017 · 24 MIN
Clinical Research, Big Data and Advocacy: An Interview with Nancy Brinker
from The Onco'Zine Brief with Peter Hofland · host Peter Hofland
This episode of The Onco'Zine Brief is an interview with Nancy Brinker, founder of Susan G. Komen for the Cure. This program was originally recorded and broadcast during the Annual Meeting of the American Association of Cancer Research - AACR, held – April 16 – 20, 2016, in New Orleans, Louisiana. It can be said that Nancy Brinker embodies the global movement to end breast cancer. Over the last 4 decades we’ve seen major developments and advances in the in diagnosis and treatment of cancer. Among the major changes seen is the rise of patient advocacy and how patient advocacy helps patients, their families, and their caregivers navigate the cancer landscape. The organization Nancy Brinker founded, has been a leading force in the development of patient advocacy and has changed the way the world talks about and treats breast cancer.
What this episode covers
This episode of The Onco'Zine Brief is an interview with Nancy Brinker, founder of Susan G. Komen for the Cure. This program was originally recorded and broadcast during the Annual Meeting of the American Association of Cancer Research - AACR, held – April 16 – 20, 2016, in New Orleans, Louisiana. It can be said that Nancy Brinker embodies the global movement to end breast cancer. Over the last 4 decades we’ve seen major developments and advances in the in diagnosis and treatment of cancer. Among the major changes seen is the rise of patient advocacy and how patient advocacy helps patients, their families, and their caregivers navigate the cancer landscape. The organization Nancy Brinker founded, has been a leading force in the development of patient advocacy and has changed the way the world talks about and treats breast cancer.
NOW PLAYING
Clinical Research, Big Data and Advocacy: An Interview with Nancy Brinker
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m